Literature DB >> 29299753

Factors Associated with the Outcome of Very Elderly Patients with Large Hemispheric Infarction Treated with Medical Management Only.

Sudhir Datar1, Christopher McLouth2, Patrick Reynolds3.   

Abstract

BACKGROUND: Large ischemic stroke in the very elderly population is presumed to invariably carry a poor prognosis and clinicians may refrain from continuing intensive care. Many elderly patients are not surgical candidates, and there is a paucity of data outlining the real-world outcomes of continued medical management. Our objective is to identify the factors associated with the outcome of very elderly patients with large hemispheric infarction (LHI) treated with medical management alone.
METHODS: We performed a retrospective review of all consecutive adults ≥ 70 years of age with LHI identified from a single center stroke registry between 2012 and 2016. Mean volume of infarction was calculated using the ABC/2 method.
RESULTS: Of a total of 2335 patients, 71 (mean age 81 ± 7 years,) met inclusion criteria. Forty-one were women (58%). Mean admission National Institute of Health Stroke Score (NIHSS) was 21 ± 6. Intravenous tPA was administered in 30 (42%) and 9 (13%) patients underwent thrombectomy. Mean infarct volume was 175 ± 75 cc. Twenty-seven patients (38%) survived to hospital discharge; 6 (9%) eventually went home (albeit with mRS 4) and one (1%) went to assisted living. Multivariate logistic regression analysis found that admission NIHSS ≥ 20 (p = 0.0007) and mechanical ventilation within 48 h of admission (p = 0.0396) were independently associated with poor outcome.
CONCLUSION: Ten percent of medically managed patients (≥ 70 years of age) with LHI can go home or to assisted living, but with a mRS of 4. Whether this is an acceptable outcome must be individualized on a case-by-case basis; however, poor prognosis should not be automatically presumed solely based on the combination of older age and a large stroke.

Entities:  

Keywords:  Cerebral edema; Herniation; Large hemispheric infarction; Malignant MCA stroke; Malignant ischemic stroke

Mesh:

Year:  2018        PMID: 29299753     DOI: 10.1007/s12028-017-0484-6

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  23 in total

1.  Withholding and withdrawal of life support from the critically ill.

Authors:  N G Smedira; B H Evans; L S Grais; N H Cohen; B Lo; M Cooke; W P Schecter; C Fink; E Epstein-Jaffe; C May
Journal:  N Engl J Med       Date:  1990-02-01       Impact factor: 91.245

2.  10-Year Institutional Retrospective Case Series of Decompressive Craniectomy for Malignant Middle Cerebral Artery Infarction (mMCAI).

Authors:  Simon Lammy; Basel Al-Romhain; Laura Osborne; Edward J St George
Journal:  World Neurosurg       Date:  2016-09-14       Impact factor: 2.104

3.  A national survey of end-of-life care for critically ill patients.

Authors:  T J Prendergast; M T Claessens; J M Luce
Journal:  Am J Respir Crit Care Med       Date:  1998-10       Impact factor: 21.405

4.  Increasing incidence of withholding and withdrawal of life support from the critically ill.

Authors:  T J Prendergast; J M Luce
Journal:  Am J Respir Crit Care Med       Date:  1997-01       Impact factor: 21.405

5.  Evidence-based guidelines for the management of large hemispheric infarction : a statement for health care professionals from the Neurocritical Care Society and the German Society for Neuro-intensive Care and Emergency Medicine.

Authors:  Michel T Torbey; Julian Bösel; Denise H Rhoney; Fred Rincon; Dimitre Staykov; Arun P Amar; Panayiotis N Varelas; Eric Jüttler; DaiWai Olson; Hagen B Huttner; Klaus Zweckberger; Kevin N Sheth; Christian Dohmen; Ansgar M Brambrink; Stephan A Mayer; Osama O Zaidat; Werner Hacke; Stefan Schwab
Journal:  Neurocrit Care       Date:  2015-02       Impact factor: 3.210

6.  Predicting prognosis after stroke: a placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-PA Stroke Trial.

Authors:  M R Frankel; L B Morgenstern; T Kwiatkowski; M Lu; B C Tilley; J P Broderick; R Libman; S R Levine; T Brott
Journal:  Neurology       Date:  2000-10-10       Impact factor: 9.910

7.  DESTINY-S: attitudes of physicians toward disability and treatment in malignant MCA infarction.

Authors:  Hermann Neugebauer; Claire J Creutzfeldt; J Claude Hemphill; Peter U Heuschmann; Eric Jüttler
Journal:  Neurocrit Care       Date:  2014-08       Impact factor: 3.210

8.  Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial.

Authors:  Jeannette Hofmeijer; L Jaap Kappelle; Ale Algra; G Johan Amelink; Jan van Gijn; H Bart van der Worp
Journal:  Lancet Neurol       Date:  2009-03-05       Impact factor: 44.182

9.  Glyburide Advantage in Malignant Edema and Stroke (GAMES-RP) Trial: Rationale and Design.

Authors:  Kevin N Sheth; Jordan J Elm; Lauren A Beslow; Gordon K Sze; W Taylor Kimberly
Journal:  Neurocrit Care       Date:  2016-02       Impact factor: 3.210

10.  Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery (DESTINY): a randomized, controlled trial.

Authors:  Eric Jüttler; Stefan Schwab; Peter Schmiedek; Andreas Unterberg; Michael Hennerici; Johannes Woitzik; Steffen Witte; Ekkehart Jenetzky; Werner Hacke
Journal:  Stroke       Date:  2007-08-09       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.